Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT04434404
Eligibility Criteria:
Inclusion Criteria:
* cancer patients receiving anthracycline chemotherapy in their protocol alone (without any cardioprotective agent),
* aged 20-60 and
* female patients were included.
Exclusion Criteria:
* patients with a history of heart failure, arrhythmia, history of cardiac catheterizations or, history of angina, uncontrolled hypertension and uncontrolled diabetes,
* patients with impaired liver function tests,
* previous anthracycline-containing regimens and any cardiotoxic chemotherapy regimens,
* previous history of chest wall irradiation.
* Brain metastasis,
* pregnant patients and
* patients who refused informed consent,
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
60 Years
Study:
NCT04434404
Study Brief:
Protocol Section:
NCT04434404